Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.45 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29581614 | 1.00 | THRA (0.53) | THRATHRBPPARDMTNR1AMTNR1B | |
| SCHEMBL1839978 | 0.96 | THRA (0.50) | THRATHRBPPARDMTNR1AMTNR1B | |
| SCHEMBL1838972 | 0.93 | THRA (0.58) | THRATHRBPPARDMTNR1AMTNR1B | |
| SCHEMBL6119606 | 0.92 | THRA (0.47) | THRATHRBPPARDMTNR1AMTNR1B | |
| SCHEMBL1840358 | 0.92 | THRA (0.65) | THRATHRBPPARDLTB4RLTB4R2 | |
| SCHEMBL1840142 | 0.92 | THRA (0.47) | THRATHRBPPARDMTNR1AMTNR1B | |
| SCHEMBL1836742 | 0.91 | KDM4E (0.53) | THRATHRBPPARDMTNR1AMTNR1B | |
| SCHEMBL1834701 | 0.90 | THRA (0.68) | THRATHRBLTB4RLTB4R2PPARG | |
| SCHEMBL1836294 | 0.90 | THRA (0.68) | THRATHRBLTB4RLTB4R2PPARG | |
| SCHEMBL1838327 | 0.90 | THRA (0.68) | THRATHRBLTB4RLTB4R2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| EP-3838892-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2022-10-12 | — | — | EP | disclosed |
| CN-115023837-A | Electrolyte solution | 奥升德功能材料运营有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-109803992-B | Isocyanate composition and method for producing isocyanate polymer | 旭化成株式会社 | 2022-05-24 | — | — | CN | disclosed |
| EP-3536683-B1 | POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2021-11-24 | — | — | EP | disclosed |
| US-11174337-B2 | Isocyanate composition, method for producing isocyanate polymer and isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-11-16 | — | — | US | disclosed |
| US-6790928-B2 | THERMAL STABILITY IMPROVED BY ADDITION OF PHOSPHITE; TRANSESTERIFICATION; POLYCONDENSING A CARBONIC ACID DIESTER WITH A DIHYDROXY COMPOUND IN A MOLTEN STATE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-09-14 | — | — | US | disclosed |
| US-20030195326-A1 | Process for producing polycarbonates | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-10-16 | — | — | US | disclosed |
| EP-1327665-A1 | PROCESS FOR PRODUCING POLYCARBONATE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-07-16 | — | — | EP | disclosed |
| US-6197918-B1 | INTERCHANGE REACTION OF DIALKYL CARBONATE AND AROMATIC ALCOHOL; CATALYSIS WITH TITANIUM HALIDE, ALKOXIDE, ARYLOXIDE, OR ACETOXIDE | GENERAL ELECTRIC COMPANY | 2001-03-06 | — | — | US | disclosed |
| EP-0591923-B1 | Continuous production of aromatic carbonates | DAICEL CHEM (JP) | 1998-08-26 | — | — | EP | disclosed |
| US-5380908-A | From alkylaryl carbonates produced from dialkyl carbonates and a phenol, distillation of alcohol | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-01-10 | — | — | US | disclosed |
| EP-0591923-A1 | Continuous production of aromatic carbonates | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1994-04-13 | — | — | EP | disclosed |
| US-5008353-A | Organic peroxide having a polymerization-regulating ability | NIPPON OIL AND FATS CO., LTD. (JP) | 1991-04-16 | — | — | US | disclosed |
| US-4929747-A | POLYMERIZATION CATALYSTS | NIPPON OIL & FATS COMPANY, LTD. (JP) | 1990-05-29 | — | — | US | disclosed |
| US-4495362-A | ALKYL PHENYL CARBONATE REACTED WITH A NITROPARAFFIN IN THE PRESENCE OF A CYANIDE ION | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1985-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | THRA 4860/4885THRB 4881/4885PPARD 3365/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | THRA 4856/4885THRB 4879/4885PPARD 3484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.